CXCL14 is increased in the invasive front of PDAC specimens, and treatment with CXCL14 significantly increases the invasiveness of pancreatic cancer cells, suggesting that CXCL14 may function as an oncogene in PDAC [58]. Here, CXCL14 is linked to pancreatic neoplasm.